Rescheduling could affect research, business taxation, prescribing pathways, and public policy, but it would not automatically convert every state dispensary product into an FDA-approved prescription drug or every purchase into a qualified medical expense. Watch the final DEA rule, its effective date, Treasury and IRS guidance, and benefit-administrator updates.
Educational use: This page does not provide medical, legal, tax or benefits advice.